Abstract

The discovery of vascular endothelial-derived growth factor (VEGF) has revolutionized our understanding of vasculogenesis and angiogenesis during development and physiological homeostasis. Over a short span of two decades, our understanding of the molecular mechanisms by which VEGF coordinates neurovascular homeostasis has become more sophisticated. The central role of VEGF in the pathogenesis of diverse cancers and blinding eye diseases has also become evident. Elucidation of the molecular regulation of VEGF and the transformative development of multiple therapeutic pathways targeting VEGF directly or indirectly is a powerful case study of how fundamental research can guide innovation and translation. It is also an elegant example of how agnostic discovery and can transform our understanding of human disease. This review will highlight critical nodal points in VEGF biology, including recent developments in immunotherapy for cancer and multitarget approaches in neovascular eye disease.

Keywords

BiologyDiseaseComputational biologySignal transductionGeneticsEvolutionary biologyBioinformaticsInternal medicine

MeSH Terms

AnimalsHumansImmunotherapyNeoplasmsRetinal VesselsSignal TransductionVascular Endothelial Growth Factor AVascular Endothelial Growth Factors

Affiliated Institutions

Related Publications

Fibroblasts in cancer

Tumours are known as wounds that do not heal - this implies that cells that are involved in angiogenesis and the response to injury, such as endothelial cells and fibroblasts, h...

2006 Nature reviews. Cancer 4355 citations

Publication Info

Year
2019
Type
review
Volume
176
Issue
6
Pages
1248-1264
Citations
2499
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

2499
OpenAlex
76
Influential
2193
CrossRef

Cite This

Rajendra S. Apte, Daniel S. Chen, Napoleone Ferrara (2019). VEGF in Signaling and Disease: Beyond Discovery and Development. Cell , 176 (6) , 1248-1264. https://doi.org/10.1016/j.cell.2019.01.021

Identifiers

DOI
10.1016/j.cell.2019.01.021
PMID
30849371
PMCID
PMC6410740

Data Quality

Data completeness: 90%